Clinical Diagnostics Market
Market Insights on Clinical Diagnostics covering sales outlook, demand forecast & up-to-date key trends
Clinical Diagnostics Market By Product, Test, End-User & Region - Forecast 2022-2032
Clinical Diagnostics Market Outlook (2022-2032)
[293 Pages Report] The global clinical diagnostics market is expected to reach a valuation of US$ 126.6 Billion in 2032. With growing popularity of blood tests and other tests through clinical diagnostics, the overall sales of clinical diagnostics products are projected to grow at a robust CAGR of 5.5% between 2022 and 2032, totaling around US$ 74 Billion by the end of 2022.
|
Clinical Diagnostics Market Size (2032) |
US$ 126.6 Billion |
|
Clinical Diagnostics Market Revenue Forecast (2022) |
US$ 74 Billion |
|
Clinical Diagnostics Market Growth Rate (2022-2032) |
5.5% CAGR |
The process of identifying a disease, condition, or injury based on the signs and symptoms a patient is having and the patient’s health history and physical exam. Further testing, such as blood tests, imaging tests, and biopsies, may be done after a clinical diagnosis is made.
Clinical Diagnostics are medical devices used to perform diagnostic tests on biological samples such as blood, urine, and tissues. These tests help detect and monitor infectious diseases, autoimmune diseases, and several medical conditions that are being used to analyze drug therapies.
In addition, technological advancements such as rapid test kits for Clinical Diagnostics industry have expanded at an astounding rate in recent years and is expected to continue in the future. Clinical diagnostics is applied to various aspects in healthcare.
Furthermore, there has been a rise in use of clinical testing across the globe. This is attributed to surge in awareness toward point-of-care testing. For instance, key players are focused on launching new transportable, portable, and handheld instruments, which can be easily used outside laboratory settings.
Thus, this leads to rise in demand among healthcare professionals and patients. In addition, high sensitivity and specificity associated with in vitro diagnostic testing also plays a major role toward their adoption. Hence, the factors mentioned above contribute to Clinical diagnostics market growth.
Let us know your requirement to get
100% FREE customization
Clinical Diagnostics Demand Analysis (2015 To 2021) Vs Market Outlook (2022 To 2032)
“Rising Prevalence of Chronic Diseases, High Investments in R&D, and Innovations in Clinical Diagnostics Systems Augmenting Clinical Diagnostics Market Growth
As per Future Market Insights, the global demand for clinical diagnostics is anticipated to grow at a healthy CAGR of 5.5% during the forecast period between 2022 and 2032, in comparison to 6.1% CAGR registered from 2015 to 2021.
As per the Non-communicable Diseases Key Facts published by the World Health Organization (WHO), in April 2021, chronic diseases kill around 41 million people each year, which is equivalent to 71% of all deaths worldwide.
Owing to the increase in chronic diseases, the demand for healthcare systems is also increasing. Clinical diagnostics have, thus, proven to be beneficial in chronic disease conditions, and are found to be valuable for disease prevention, detection, and management.
Clinical diagnostics help detect early warning signs and individual risk factors, creating new opportunities for prevention and early intervention. Thus, the increasing incidence of chronic diseases is expected to propel the overall market further.
Growth can be attributed to the increasing adoption of clinical diagnostics, attributed to the rise in testing due to the pandemic. The development of automated clinical diagnostics systems for laboratories and hospitals to provide efficient, accurate, and error-free diagnoses is expected to boost the market growth over the analysis period.
The rising number of clinical diagnostics products being launched by key players is also augmenting the growth of the market. Clinical diagnostics products with molecular diagnostic capabilities deliver effective and accurate results.
The market is expected to grow, owing to the increasing incidence of infectious and chronic diseases and the increasing adoption of automated platforms. The rising number of tests owing to the constant upsurge in patients and funding by governments are the factors that are expected to escalate the demand for COVID-19 test kits and drive the overall market growth exponentially.
The rising demand for point-of-care clinical diagnostics devices and the increasing adoption of these devices have been instrumental in driving the market growth. This is further augmented by increasing investment by key players in research & development to innovate products and explore new applications of clinical diagnostics techniques.
Which Factors Are Restraining The Growth Of Clinical Diagnostics Market?
High Cost of Clinical Diagnostics Instruments to Impede Growth in Emerging Countries
Clinical diagnostics products have witnessed significant advancements and developments in the past decade regarding new products being adopted and further design amendments. However, the high cost of Clinical diagnostics instruments and the high cost associated with the maintenance of the instruments have hindered the market growth to a certain extent.
Furthermore, clinical diagnostics instruments require skilled professionals for operation. Thus, this increases the maintenance cost of the device, which ultimately hinders the overall growth of the market.
The cost of RT-PCR systems ranges from USD 15,000 to over USD 90,000. The above cost factors have been responsible for the relatively limited adoption of clinical diagnostics products in several countries and regions.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystCountry-Wise Analysis
Which Factors are pushing the Clinical Diagnostics Devices in the U.S?
“Rising Prevalence of Cancer and Increasing Need for Early Diagnosis and Detection of Tumors are pushing the Demand for Clinical Diagnostics in the U.S”
The U.S is expected to hold the largest share of US$ 43.8 Billion in the global Clinical Diagnostics Market, and is expected to reach at a CAGR of 5.0% over the analysis period.
Over the years, sales of clinical diagnostics products have risen at a substantial pace across the US and the trend is likely to continue even during the forecast period, owing to the increasing geriatric population, rising patient awareness about the value of laboratory tests, and the rising prevalence of infectious and chronic disease patients.
The increasing number of COVID-19 infections has led to increased funding and an increasing number of testing, which has boosted the overall market growth. For instance, in September 2020, the National Institutes of Health, US, announced its plan to give funding of USD 129.3 million to nine companies, including MatMaCorp, Maxim Biomedical Inc., MicroGEM International, etc., to scale-up manufacturing support for a new set of COVID-19 testing technologies as part of its Rapid Acceleration of Diagnostics (RADx) initiative.
As per the Centers for Disease Control and Prevention (CDC), in the United States, four in ten adults have two or more chronic diseases, and six in ten adults have a chronic disease. Chronic diseases such as cancer, heart disease, and diabetes are the leading causes of death and disability in the United States and are leading drivers of the USD 3.8 trillion spent in annual health care costs.
This has led to a higher demand for better treatment with efficient management, further driving the market in the United States. Hence, the increasing prevalence of infectious and chronic diseases and the growing awareness of the value of laboratory tests are expected to fuel the market growth in the country.
How Will Growth Unfold in China Clinical Diagnostics Market?
“Increasing Demand for Safe and Noninvasive Imaging Technologies for the Diagnosis of various Diseases Creating Space for the Clinical Diagnostics Market in China”
As per FMI, China is anticipated to be the second-most dominant country in terms of clinical diagnostics market share. The market in China holds a significant share due to rising healthcare expenditure, well-established infrastructure, and a large pool of patients suffering from infectious diseases and cancer.
In addition, the growing population and emerging advancements in technologies are the major factors that are expected to fuel the market growth. The market in China is estimated to grow at the highest CAGR, attributed to the improving approval & reimbursement policies and rising per capita healthcare expenditure in the country.
China is expected to hold the largest share of US$ 9.2 Billion in the global clinical diagnostics market, and is expected to reach at a CAGR of 5.0% over the analysis period.
Category-Wise Analysis
Which Tests Segment Dominates the Global Clinical Diagnostics Market?
“Lipid Panel Tests to Grow Exponentially During the Forecast Period”
Based on test, the Lipid Tests Panel of the global clinical diagnostics market is likely to account for the largest share of 5.5%, in the global clinical diagnostics market during the forecast period.
The lipid panel is a blood test that measures the lipids, fats, and fatty substances used as a source of energy by the body. The lipid panel includes tests for total cholesterol, HDL cholesterol, triglycerides, LDL cholesterol, cholesterol/HDL ratio, and non-HDL cholesterol.
Many studies have observed a decrease in total cholesterol, LDL-C, and HDL-C levels in patients with COVID-19 infections. Based on various studies, the decrease in LDL-C and/or HDL-C was more profound with greater severity of the illness.
Therefore, patients with low HDL-C levels during admission to the hospital were at an increased risk of developing a severe disease compared to patients with high HDL-C levels, which has boosted the test demand. With the recovery from COVID-19, the serum lipid levels return to levels present before infection.
A lipid panel measures the level of specific lipids in blood to assess the risk of cardiovascular disease and is used in screening populations to identify subjects with a high risk of developing a cardiac event.
According to Cardiovascular Diseases Key Facts published by the World Health Organization, in June 2021, cardiovascular diseases (CVDs) are the leading cause of death globally, accounting for around 32% of all global deaths. Moreover, over three-quarters of CVD deaths take place in middle- and low-income countries.
Hence, with an increase in the prevalence and mortality rate of cardiovascular diseases, there is an increase in the requirement of lipid profile testing at an early stage, which is driving the lipid panel segment. Key companies are focusing on novel product developments and launches to leverage potential opportunities. Hence, the segment is estimated to grow over the forecast period due to the aforementioned factors.
Which Product Type Holds the Maximum Potential for Clinical Diagnostics Market Growth?
“Instruments to Remain the Most Lucrative Product Type of Clinical Diagnostics Systems”
Future Market Insights’ latest clinical diagnostics market forecast estimates the instruments segment to grow at a CAGR of 5.0% during the assessment period. Growth of this segment is attributed to the continuous innovations in the instruments used in the process of the Clinical Diagnostics.
Additionally, rising adoption of advanced instruments in the setting, along with rapid investments by public and private sectors in laboratory infrastructure in developing countries is another factor that is expected to boost the segment’s growth over the analysis period.
Furthermore, most complex and sensitive diagnostic tests are carried out in laboratories and require skilled lab staff, specialized equipment, and slightly more time to run.
The instruments segment is projected to grow at a substantial CAGR during the forecast period. Due to the increased burden of patient populations suffering from various diseases (diabetes, infectious disease, HIV), medical device giants are focusing on introducing innovative and accurate testing kits.
Who is the Leading End User of Clinical Diagnostics Products?
“Demand for Clinical Diagnostics Products to Remain High in Hospital Laboratory Segment”
As per FMI, the hospital laboratory segment is anticipated to account for the largest share of the clinical diagnostics market in 2022. Factors such as rapid rise in the number of hospital laboratories worldwide, increasing frequency of patient visits to hospitals, and escalating government efforts to make various treatments and diagnostic technologies available in hospitals are spurring the growth of this segment.
Emerging clinical diagnostics market trends indicate the hospital laboratory segment to grow at the highest CAGR during the assessment period between 2022 and 2032.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Role Of Start-Ups In Clinical Diagnostics Market
There are many prominent market players in the clinical diagnostics market, who are working hand-in-hand to provide the best-in-class Clinical Diagnostics for enhancing the global arena. However, there are many global start-ups in the clinical diagnostics market, who are stepping forward in matching the requirements of the clinical diagnostics domain.
Global Startups of Clinical Diagnostics Market
- Thyrocare Aarogyam
- Lal Pathlabs
- Metropolis Pathology
- Apollo Diagnostics
- SRL Diagnostics
- bioMérieux
- Danaher Corporation
- Quest Diagnostics
- Siemens Healthineers
- Sysmex Corporation
Who Are The Leading Players In Clinical Diagnostics Market?
Some of the leading clinical diagnostics service providers include Abbott Laboratories, Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Siemens AG, Hologic Inc., Qiagen NV, Hoffmann-La Roche AG, Thermo Fisher Scientific, Quest Diagnostics Inc., and Charles River Laboratories, among others.
These key clinical diagnostics system providers are adopting various strategies such as new product launches and approvals, partnerships, collaborations, acquisitions, mergers, etc. to increase their sales and gain a competitive edge in the global clinical diagnostics market.
For instance,
- In January 2022, the Therapeutic Goods Administration (TGA) granted provisional approval for Novavax's COVID-19 vaccine branded as Nuvaxovid for use in Australia.
- In September 2021, Ortho Clinical Diagnostics announced the availability of Immediate Spin Crossmatch (ISXM) on the company’s Ortho Vision and Ortho Vision Max Analyzers to aid in detecting incompatibility between recipients and donors in blood transfusions.
- In March 2021, F. Hoffmann-La Roche Ltd. signed a definitive merger agreement with GenMark Diagnostics Inc. This acquisition will help Roche access GenMark’s novel technology to test for a broad range of pathogens with one patient sample.
Report Scope
|
Report Attribute |
Details |
|
Growth Rate |
CAGR of 5.5% from 2022 to 2032 |
|
Market Value in 2022 |
US$ 74 Billion |
|
Market Value in 2032 |
US$ 126.6 Billion |
|
Base Year for Estimation |
2021 |
|
Historical Data |
2015-2021 |
|
Forecast Period |
2022-2032 |
|
Quantitative Units |
Revenue in US$ Million, Volume in Kilotons and CAGR from 2022-2032 |
|
Report Coverage |
Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
|
Segments Covered |
|
|
Regions Covered |
|
|
Key Countries Profiled |
|
|
Key Companies Profiled |
|
|
Customization |
Available Upon Request |
Key Segments Of Clinical Diagnostics Industry Survey
Clinical Diagnostics Market by Test:
- Lipid Panel Clinical Diagnostics
- Liver Panel Clinical Diagnostics
- Renal Panel Clinical Diagnostics
- Complete Blood Count Clinical Diagnostics
- Clinical Diagnostics for Electrolyte Testing
- Clinical Diagnostics for Infectious Disease Testing
- Other Clinical Diagnostics Tests
Clinical Diagnostics Market by Product:
- Clinical Diagnostics Instruments
- Clinical Diagnostics Reagents
- Other Clinical Diagnostics Products
Clinical Diagnostics Market by End-User:
- Clinical Diagnostics for Hospital Laboratories
- Clinical Diagnostics for Diagnostic Laboratories
- Clinical Diagnostics for Point-of-Care Testing
- Clinical Diagnostics for Other End-Users
Clinical Diagnostics Market by Region:
- North America Clinical Diagnostics Market
- Latin America Clinical Diagnostics Market
- Europe Clinical Diagnostics Market
- Asia Pacific Clinical Diagnostics Market
- Middle East & Africa (MEA) Clinical Diagnostics Market
Frequently Asked Questions
The global clinical diagnostics market is expected to reach US$ 126.6 Billion in 2032
As per Future Market Insights, the clinical diagnostics industry is expected to grow at a CAGR of 5.5% throughout the forecast period (2022-2032).
The clinical diagnostics systems market is anticipated to reach a valuation of US$ 74 Billion by 2022
The U.S is the most lucrative market for clinical diagnostics systems, registering a 5% CAGR until 2032
China is forecast to accumulate a market value of US$ 9.2 Billion by the end of the 2022-2032 period of assessment
Clinical diagnostics instruments are anticipated to be the most demanded, growing at a CAGR of 5%
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on Clinical Diagnostic
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ Bn)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends
4. Market Background
4.1. Clinical Diagnostic Market, by Key Countries
4.2. Clinical Diagnostic Market Opportunity Assessment (US$ Bn)
4.2.1. Total Available Market
4.2.2. Serviceable Addressable Market
4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors - Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Growth in Automation, By Country
4.5.3. Clinical Diagnostic Adoption Rate, By Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. Clinical Diagnostic Market Opportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
5. Key Success Factors
5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking
6. Global Clinical Diagnostic Market Demand Analysis 2015-2021 and Forecast, 2022-2032
6.1. Historical Market Analysis, 2015-2021
6.2. Current and Future Market Projections, 2022-2032
6.3. Y-o-Y Growth Trend Analysis
7. Global Clinical Diagnostic Market Value Analysis 2015-2021 and Forecast, 2022-2032
7.1. Historical Market Value (US$ Bn) Analysis, 2015-2021
7.2. Current and Future Market Value (US$ Bn) Projections, 2022-2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Clinical Diagnostic Market Analysis 2015-2021 and Forecast 2022-2032, By Test
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Bn) Analysis By Test, 2015-2021
8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Test, 2022-2032
8.3.1. Lipid Panel
8.3.2. Liver Panel
8.3.3. Renal Panel
8.3.4. Complete Blood Count
8.3.5. Electrolyte Testing
8.3.6. Infectious Disease Testing
8.3.7. Other Tests
8.4. Market Attractiveness Analysis By Test
9. Global Clinical Diagnostic Market Analysis 2015-2021 and Forecast 2022-2032, By Product
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Bn) Analysis By Product, 2015-2021
9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Product, 2022-2032
9.3.1. Instruments
9.3.2. Reagents
9.3.3. Other Products
9.4. Market Attractiveness Analysis By Product
10. Global Clinical Diagnostic Market Analysis 2015-2021 and Forecast 2022-2032, By End-user
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Bn) Analysis By End-user, 2015-2021
10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By End-user, 2022-2032
10.3.1. Hospital Laboratory
10.3.2. Diagnostic Laboratory
10.3.3. Point-of-care Testing
10.3.4. Other End Users
10.4. Market Attractiveness Analysis By End-user
11. Global Clinical Diagnostic Market Analysis 2015-2021 and Forecast 2022-2032, By Region
11.1. Introduction
11.2. Historical Market Size (US$ Bn) Analysis By Region, 2015-2021
11.3. Current Market Size (US$ Bn) & Analysis and Forecast By Region, 2022-2032
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. Asia Pacific
11.3.5. Middle East and Africa (MEA)
11.4. Market Attractiveness Analysis By Region
12. North America Clinical Diagnostic Market Analysis 2015-2021 and Forecast 2022-2032
12.1. Introduction
12.2. Pricing Analysis
12.3. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2015-2021
12.4. Market Size (US$ Bn) & Forecast By Market Taxonomy, 2022-2032
12.4.1. By Country
12.4.1.1. U.S.
12.4.1.2. Canada
12.4.1.3. Rest of North America
12.4.2. By Test
12.4.3. By End-user
12.4.4. By Product
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Test
12.5.3. By End-user
12.5.4. By Product
13. Latin America Clinical Diagnostic Market Analysis 2015-2021 and Forecast 2022-2032
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2015-2021
13.4. Market Size (US$ Bn) & Forecast By Market Taxonomy, 2022-2032
13.4.1. By Country
13.4.1.1. Brazil
13.4.1.2. Mexico
13.4.1.3. Rest of Latin America
13.4.2. By Test
13.4.3. By End-user
13.4.4. By Product
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Test
13.5.3. By End-user
13.5.4. By Product
14. Europe Clinical Diagnostic Market Analysis 2015-2021 and Forecast 2022-2032
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2015-2021
14.4. Market Size (US$ Bn) & Forecast By Market Taxonomy, 2022-2032
14.4.1. By Country
14.4.1.1. Germany
14.4.1.2. France
14.4.1.3. U.K.
14.4.1.4. Italy
14.4.1.5. Benelux
14.4.1.6. Nordic Countries
14.4.1.7. Rest of Europe
14.4.2. By Test
14.4.3. By End-user
14.4.4. By Product
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Test
14.5.3. By End-user
14.5.4. By Product
15. Asia Pacific Clinical Diagnostic Market Analysis 2015-2021 and Forecast 2022-2032
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2015-2021
15.4. Market Size (US$ Bn) & Forecast By Market Taxonomy, 2022-2032
15.4.1. By Country
15.4.1.1. China
15.4.1.2. Japan
15.4.1.3. South Korea
15.4.1.4. Rest of Asia Pacific
15.4.2. By Test
15.4.3. By End-user
15.4.4. By Product
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Test
15.5.3. By End-user
15.5.4. By Product
16. Middle East and Africa Clinical Diagnostic Market Analysis 2015-2021 and Forecast 2022-2032
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2015-2021
16.4. Market Size (US$ Bn) & Forecast By Market Taxonomy, 2022-2032
16.4.1. By Country
16.4.1.1. GCC Countries
16.4.1.2. South Africa
16.4.1.3. Turkey
16.4.1.4. Rest of Middle East and Africa
16.4.2. By Test
16.4.3. By End-user
16.4.4. By Product
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Test
16.5.3. By End-user
16.5.4. By Product
17. Key Countries Clinical Diagnostic Market Analysis 2015-2021 and Forecast 2022-2032
17.1. Introduction
17.1.1. Market Value Proportion Analysis, By Key Countries
17.1.2. Global Vs. Country Growth Comparison
17.2. US Clinical Diagnostic Market Analysis
17.2.1. Value Proportion Analysis by Market Taxonomy
17.2.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.2.2.1. By Test
17.2.2.2. By End-user
17.2.2.3. By Product
17.3. Canada Clinical Diagnostic Market Analysis
17.3.1. Value Proportion Analysis by Market Taxonomy
17.3.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.3.2.1. By Test
17.3.2.2. By End-user
17.3.2.3. By Product
17.4. Mexico Clinical Diagnostic Market Analysis
17.4.1. Value Proportion Analysis by Market Taxonomy
17.4.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.4.2.1. By Test
17.4.2.2. By End-user
17.4.2.3. By Product
17.5. Brazil Clinical Diagnostic Market Analysis
17.5.1. Value Proportion Analysis by Market Taxonomy
17.5.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.5.2.1. By Test
17.5.2.2. By End-user
17.5.2.3. By Product
17.6. Germany Clinical Diagnostic Market Analysis
17.6.1. Value Proportion Analysis by Market Taxonomy
17.6.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.6.2.1. By Test
17.6.2.2. By End-user
17.6.2.3. By Product
17.7. France Clinical Diagnostic Market Analysis
17.7.1. Value Proportion Analysis by Market Taxonomy
17.7.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.7.2.1. By Test
17.7.2.2. By End-user
17.7.2.3. By Product
17.8. Italy Clinical Diagnostic Market Analysis
17.8.1. Value Proportion Analysis by Market Taxonomy
17.8.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.8.2.1. By Test
17.8.2.2. By End-user
17.8.2.3. By Product
17.9. BENELUX Clinical Diagnostic Market Analysis
17.9.1. Value Proportion Analysis by Market Taxonomy
17.9.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.9.2.1. By Test
17.9.2.2. By End-user
17.9.2.3. By Product
17.10. UK Clinical Diagnostic Market Analysis
17.10.1. Value Proportion Analysis by Market Taxonomy
17.10.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.10.2.1. By Test
17.10.2.2. By End-user
17.10.2.3. By Product
17.11. Nordic Countries Clinical Diagnostic Market Analysis
17.11.1. Value Proportion Analysis by Market Taxonomy
17.11.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.11.2.1. By Test
17.11.2.2. By End-user
17.11.2.3. By Product
17.12. China Clinical Diagnostic Market Analysis
17.12.1. Value Proportion Analysis by Market Taxonomy
17.12.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.12.2.1. By Test
17.12.2.2. By End-user
17.12.2.3. By Product
17.13. Japan Clinical Diagnostic Market Analysis
17.13.1. Value Proportion Analysis by Market Taxonomy
17.13.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.13.2.1. By Test
17.13.2.2. By End-user
17.13.2.3. By Product
17.14. South Korea Clinical Diagnostic Market Analysis
17.14.1. Value Proportion Analysis by Market Taxonomy
17.14.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.14.2.1. By Test
17.14.2.2. By End-user
17.14.2.3. By Product
17.15. GCC Countries Clinical Diagnostic Market Analysis
17.15.1. Value Proportion Analysis by Market Taxonomy
17.15.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.15.2.1. By Test
17.15.2.2. By End-user
17.15.2.3. By Product
17.16. South Africa Clinical Diagnostic Market Analysis
17.16.1. Value Proportion Analysis by Market Taxonomy
17.16.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.16.2.1. By Test
17.16.2.2. By End-user
17.16.2.3. By Product
17.17. Turkey Clinical Diagnostic Market Analysis
17.17.1. Value Proportion Analysis by Market Taxonomy
17.17.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.17.2.1. By Test
17.17.2.2. By End-user
17.17.2.3. By Product
17.17.3. Competition Landscape and Player Concentration in the Country
18. Market Structure Analysis
18.1. Market Analysis by Tier of Companies
18.2. Market Concentration
18.3. Market Share Analysis of Top Players
18.4. Market Presence Analysis
18.4.1. By Regional footprint of Players
18.4.2. Product footprint by Players
19. Competition Analysis
19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Competition Deep Dive
19.3.1. Abbott Laboratories
19.3.1.1. Overview
19.3.1.2. Product Portfolio
19.3.1.3. Sales Footprint
19.3.1.4. Strategy Overview
19.3.2. Becton, Dickinson and Company
19.3.2.1. Overview
19.3.2.2. Product Portfolio
19.3.2.3. Sales Footprint
19.3.2.4. Strategy Overview
19.3.3. BioMerieux
19.3.3.1. Overview
19.3.3.2. Product Portfolio
19.3.3.3. Sales Footprint
19.3.3.4. Strategy Overview
19.3.4. Bio-Rad Laboratories Inc.
19.3.4.1. Overview
19.3.4.2. Product Portfolio
19.3.4.3. Sales Footprint
19.3.4.4. Strategy Overview
19.3.5. Danaher Corporation
19.3.5.1. Overview
19.3.5.2. Product Portfolio
19.3.5.3. Sales Footprint
19.3.5.4. Strategy Overview
19.3.6. Siemens AG
19.3.6.1. Overview
19.3.6.2. Product Portfolio
19.3.6.3. Sales Footprint
19.3.6.4. Strategy Overview
19.3.7. Hologic Inc.
19.3.7.1. Overview
19.3.7.2. Product Portfolio
19.3.7.3. Sales Footprint
19.3.7.4. Strategy Overview
19.3.8. Qiagen NV
19.3.8.1. Overview
19.3.8.2. Product Portfolio
19.3.8.3. Sales Footprint
19.3.8.4. Strategy Overview
19.3.9. Hoffmann-La Roche AG
19.3.9.1. Overview
19.3.9.2. Product Portfolio
19.3.9.3. Sales Footprint
19.3.9.4. Strategy Overview
19.3.10. Thermo Fisher Scientific
19.3.10.1. Overview
19.3.10.2. Product Portfolio
19.3.10.3. Sales Footprint
19.3.10.4. Strategy Overview
19.3.11. Quest Diagnostics Inc.
19.3.11.1. Overview
19.3.11.2. Product Portfolio
19.3.11.3. Sales Footprint
19.3.11.4. Strategy Overview
19.3.12. Sysmex Corporation
19.3.12.1. Overview
19.3.12.2. Product Portfolio
19.3.12.3. Sales Footprint
19.3.12.4. Strategy Overview
19.3.13. Sonic Healthcare Ltd
19.3.13.1. Overview
19.3.13.2. Product Portfolio
19.3.13.3. Sales Footprint
19.3.13.4. Strategy Overview
19.3.14. Charles River Laboratories
19.3.14.1. Overview
19.3.14.2. Product Portfolio
19.3.14.3. Sales Footprint
19.3.14.4. Strategy Overview
20. Assumptions and Acronyms Used
21. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Global Clinical Diagnostic Market Value (US$ Bn), By Test, 2015 – 2021
Table 02: Global Clinical Diagnostic Market Value (US$ Bn), By Test, 2022 – 2032
Table 03: Global Clinical Diagnostic Market Value (US$ Bn), By End-user, 2015 – 2021
Table 04: Global Clinical Diagnostic Market Value (US$ Bn), By End-user, 2022 – 2032
Table 05: Global Clinical Diagnostic Market Value (US$ Bn), By Product, 2015 – 2021
Table 06: Global Clinical Diagnostic Market Value (US$ Bn), By Product, 2022 – 2032
Table 07: Global Clinical Diagnostic Market, By Region, 2015 – 2021
Table 08: Global Clinical Diagnostic Market, By Region, 2022 – 2032
Table 09: North America Clinical Diagnostic Market Value (US$ Bn), By Test, 2015 – 2021
Table 10: North America Clinical Diagnostic Market Value (US$ Bn), By Test, 2022 – 2032
Table 11: North America Clinical Diagnostic Market Value (US$ Bn), By End-user, 2015 – 2021
Table 12: North America Clinical Diagnostic Market Value (US$ Bn), By End-user, 2022 – 2032
Table 13: North America Clinical Diagnostic Market Value (US$ Bn), By Product, 2015 – 2021
Table 14: North America Clinical Diagnostic Market Value (US$ Bn), By Product, 2022 – 2032
Table 15: North America Clinical Diagnostic Market, By Country, 2015 – 2021
Table 16: North America Clinical Diagnostic Market, By Country, 2022 – 2032
Table 17: Latin America Clinical Diagnostic Market Value (US$ Bn), By Test, 2015 – 2021
Table 18: Latin America Clinical Diagnostic Market Value (US$ Bn), By Test, 2022 – 2032
Table 19: Latin America Clinical Diagnostic Market Value (US$ Bn), By End-user, 2015 – 2021
Table 20: Latin America Clinical Diagnostic Market Value (US$ Bn), By End-user, 2022 – 2032
Table 21: Latin America Clinical Diagnostic Market Value (US$ Bn), By Product, 2015 – 2021
Table 22: Latin America Clinical Diagnostic Market Value (US$ Bn), By Product, 2022 – 2032
Table 23: Latin America Clinical Diagnostic Market, By Country, 2015 – 2021
Table 24: Latin America Clinical Diagnostic Market, By Country, 2022 – 2032
Table 25: Europe Clinical Diagnostic Market Value (US$ Bn), By Test, 2015 – 2021
Table 26: Europe Clinical Diagnostic Market Value (US$ Bn), By Test, 2022 – 2032
Table 27: Europe Clinical Diagnostic Market Value (US$ Bn), By End-user, 2015 – 2021
Table 28: Europe Clinical Diagnostic Market Value (US$ Bn), By End-user, 2022 – 2032
Table 29: Europe Clinical Diagnostic Market Value (US$ Bn), By Product, 2015 – 2021
Table 30: Europe Clinical Diagnostic Market Value (US$ Bn), By Product, 2022 – 2032
Table 31: Europe Clinical Diagnostic Market, By Country, 2015 – 2021
Table 32: Europe Clinical Diagnostic Market, By Country, 2022 – 2032
Table 33: Asia Pacific Clinical Diagnostic Market Value (US$ Bn), By Test, 2015 – 2021
Table 34: Asia Pacific Clinical Diagnostic Market Value (US$ Bn), By Test, 2022 – 2032
Table 35: Asia Pacific Clinical Diagnostic Market Value (US$ Bn), By End-user, 2015 – 2021
Table 36: Asia Pacific Clinical Diagnostic Market Value (US$ Bn), By End-user, 2022 – 2032
Table 37: Asia Pacific Clinical Diagnostic Market Value (US$ Bn), By Product, 2015 – 2021
Table 38: Asia Pacific Clinical Diagnostic Market Value (US$ Bn), By Product, 2022 – 2032
Table 39: Asia Pacific Clinical Diagnostic Market, By Country, 2015 – 2021
Table 40: Asia Pacific Clinical Diagnostic Market, By Country, 2022 – 2032
Table 41: MEA Clinical Diagnostic Market Value (US$ Bn), By Test, 2015 – 2021
Table 42: MEA Clinical Diagnostic Market Value (US$ Bn), By Test, 2022 – 2032
Table 43: MEA Clinical Diagnostic Market Value (US$ Bn), By End-user, 2015 – 2021
Table 44: MEA Clinical Diagnostic Market Value (US$ Bn), By End-user, 2022 – 2032
Table 45: MEA Clinical Diagnostic Market Value (US$ Bn), By Product, 2015 – 2021
Table 46: MEA Clinical Diagnostic Market Value (US$ Bn), By Product, 2022 – 2032
Table 47: MEA Clinical Diagnostic Market, By Country, 2015 – 2021
Table 48: MEA Clinical Diagnostic Market, By Country, 2022 – 2032
Table 49: Global Clinical Diagnostic Market Incremental $ Opportunity, By Test, 2015 - 2021
Table 50: Global Clinical Diagnostic Market Incremental $ Opportunity, By End-user, 2022 – 2032
Table 51: Global Clinical Diagnostic Market Incremental $ Opportunity, By Product, 2015 - 2021
Table 52: Global Clinical Diagnostic Market Incremental $ Opportunity, By Region, 2022 – 2032
Table 53: North America Clinical Diagnostic Market Incremental $ Opportunity, By Test, 2015 - 2021
Table 54: North America Clinical Diagnostic Market Incremental $ Opportunity, By End-user, 2022 – 2032
Table 55: North America Clinical Diagnostic Market Incremental $ Opportunity, By Product, 2015 – 2021
Table 56: North America Clinical Diagnostic Market Incremental $ Opportunity, By Country, 2022 – 2032
Table 57: Latin America Clinical Diagnostic Market Incremental $ Opportunity, By Test, 2015 - 2021
Table 58: Latin America Clinical Diagnostic Market Incremental $ Opportunity, By End-user, 2022 – 2032
Table 59: Latin America Clinical Diagnostic Market Incremental $ Opportunity, By Product, 2015 - 2021
Table 60: Latin America Clinical Diagnostic Market Incremental $ Opportunity, By Country, 2022 – 2032
Table 61: Europe Clinical Diagnostic Market Incremental $ Opportunity, By Test, 2015 - 2021
Table 62: Europe Clinical Diagnostic Market Incremental $ Opportunity, By End-user, 2022 – 2032
Table 63: Europe Clinical Diagnostic Market Incremental $ Opportunity, By Product, 2015 - 2021
Table 64: Europe Clinical Diagnostic Market Incremental $ Opportunity, By Country, 2022 - 2032
Table 65: Asia Pacific Clinical Diagnostic Market Incremental $ Opportunity, By Test, 2015 - 2021
Table 66: Asia Pacific Clinical Diagnostic Market Incremental $ Opportunity, By End-user, 2022 – 2032
Table 67: Asia Pacific Clinical Diagnostic Market Incremental $ Opportunity, By Product, 2015 - 2021
Table 68: Asia Pacific Clinical Diagnostic Market Incremental $ Opportunity, By Country, 2022 – 2032
Table 69: MEA Clinical Diagnostic Market Incremental $ Opportunity, By Test, 2015 - 2021
Table 70: MEA Clinical Diagnostic Market Incremental $ Opportunity, By End-user, 2022 – 2032
Table 71: MEA Clinical Diagnostic Market Incremental $ Opportunity, By Product, 2015 - 2021
Table 72: MEA Clinical Diagnostic Market Incremental $ Opportunity, By Country, 2022 - 2032
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global Clinical Diagnostic Market Value (US$ Bn) and Year-on-Year Growth, 2015-2032
Figure 02: Global Clinical Diagnostic Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Bn
Figure 03: Global Clinical Diagnostic Market Share, By Test, 2022 & 2032
Figure 04: Global Clinical Diagnostic Market Y-o-Y Growth Projections, By Test – 2022-2032
Figure 05: Global Clinical Diagnostic Market Attractiveness Index, By Test – 2022-2032
Figure 06: Global Clinical Diagnostic Market Share, By End-user, 2022 & 2032
Figure 07: Global Clinical Diagnostic Market Y-o-Y Growth Projections, By End-user – 2022-2032
Figure 08: Global Clinical Diagnostic Market Attractiveness Index, By End-user – 2022-2032
Figure 09: Global Clinical Diagnostic Market Share, By Product, 2022 & 2032
Figure 10: Global Clinical Diagnostic Market Y-o-Y Growth Projections, By Product – 2022-2032
Figure 11: Global Clinical Diagnostic Market Attractiveness Index, By Product – 2022-2032
Figure 12: Global Clinical Diagnostic Market Share, By Region, 2022 & 2032
Figure 13: Global Clinical Diagnostic Market Y-o-Y Growth Projections, By Region – 2022-2032
Figure 14: Global Clinical Diagnostic Market Attractiveness Index, By Region – 2022-2032
Figure 15: North America Clinical Diagnostic Market Value (US$ Bn) and Year-on-Year Growth, 2015-2032
Figure 16: North America Clinical Diagnostic Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Bn
Figure 17: North America Clinical Diagnostic Market Share, By Test, 2022 & 2032
Figure 18: North America Clinical Diagnostic Market Y-o-Y Growth Projections, By Test – 2022-2032
Figure 19: North America Clinical Diagnostic Market Attractiveness Index, By Test – 2022-2032
Figure 20: North America Clinical Diagnostic Market Share, By End-user, 2022 & 2032
Figure 21: North America Clinical Diagnostic Market Y-o-Y Growth Projections, By End-user – 2022-2032
Figure 22: North America Clinical Diagnostic Market Attractiveness Index, By End-user – 2022-2032
Figure 23: North America Clinical Diagnostic Market Share, By Product, 2022 & 2032
Figure 24: North America Clinical Diagnostic Market Y-o-Y Growth Projections, By Product – 2022-2032
Figure 25: North America Clinical Diagnostic Market Attractiveness Index, By Product – 2022-2032
Figure 26: North America Clinical Diagnostic Market Share, By Country, 2022 & 2032
Figure 27: North America Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 28: North America Market Attractiveness Index, By Country – 2022-2032
Figure 29: Latin America Clinical Diagnostic Market Value (US$ Bn) and Year-on-Year Growth, 2015-2032
Figure 30: Latin America Clinical Diagnostic Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Bn
Figure 31: Latin America Clinical Diagnostic Market Share, By Test, 2022 & 2032
Figure 32: Latin America Clinical Diagnostic Market Y-o-Y Growth Projections, By Test – 2022-2032
Figure 33: Latin America Clinical Diagnostic Market Attractiveness Index, By Test – 2022-2032
Figure 34: Latin America Clinical Diagnostic Market Share, By End-user, 2022 & 2032
Figure 35: Latin America Clinical Diagnostic Market Y-o-Y Growth Projections, By End-user – 2022-2032
Figure 36: Latin America Clinical Diagnostic Market Attractiveness Index, By End-user – 2022-2032
Figure 37: Latin America Clinical Diagnostic Market Share, By Product, 2022 & 2032
Figure 38: Latin America Clinical Diagnostic Market Y-o-Y Growth Projections, By Product – 2022-2032
Figure 39: Latin America Clinical Diagnostic Market Attractiveness Index, By Product – 2022-2032
Figure 40: Latin America Clinical Diagnostic Market Share, By Country, 2022 & 2032
Figure 41: Latin America Clinical Diagnostic Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 42: Latin America Clinical Diagnostic Market Attractiveness Index, By Country – 2022-2032
Figure 43: Europe Clinical Diagnostic Market Value (US$ Bn) and Year-on-Year Growth, 2015-2032
Figure 44: Europe Clinical Diagnostic Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Bn
Figure 45: Europe Clinical Diagnostic Market Share, By Test, 2022 & 2032
Figure 46: Europe Clinical Diagnostic Market Y-o-Y Growth Projections, By Test – 2022-2032
Figure 47: Europe Clinical Diagnostic Market Attractiveness Index, By Test – 2022-2032
Figure 48: Europe Clinical Diagnostic Market Share, By End-user, 2022 & 2032
Figure 49: Europe Clinical Diagnostic Market Y-o-Y Growth Projections, By End-user – 2022-2032
Figure 50: Europe Clinical Diagnostic Market Attractiveness Index, By End-user – 2022-2032
Figure 51: Europe Clinical Diagnostic Market Share, By Product, 2022 & 2032
Figure 52: Europe Clinical Diagnostic Market Y-o-Y Growth Projections, By Product – 2022-2032
Figure 53: Europe Clinical Diagnostic Market Attractiveness Index, By Product – 2022-2032
Figure 54: Europe Clinical Diagnostic Market Share, By Country, 2022 & 2032
Figure 55: Europe Clinical Diagnostic Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 56: Europe Clinical Diagnostic Market Attractiveness Index, By Country – 2022-2032
Figure 57: MEA Clinical Diagnostic Market Value (US$ Bn) and Year-on-Year Growth, 2015-2032
Figure 58: MEA Clinical Diagnostic Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Bn
Figure 59: MEA Clinical Diagnostic Market Share, By Test, 2022 & 2032
Figure 60: MEA Clinical Diagnostic Market Y-o-Y Growth Projections, By Test – 2022-2032
Figure 61: MEA Clinical Diagnostic Market Attractiveness Index, By Test – 2022-2032
Figure 62: MEA Clinical Diagnostic Market Share, By End-user, 2022 & 2032
Figure 63: MEA Clinical Diagnostic Market Y-o-Y Growth Projections, By End-user – 2022-2032
Figure 64: MEA Clinical Diagnostic Market Attractiveness Index, By End-user – 2022-2032
Figure 65: MEA Clinical Diagnostic Market Share, By Product, 2022 & 2032
Figure 66: MEA Clinical Diagnostic Market Y-o-Y Growth Projections, By Product – 2022-2032
Figure 67: MEA Clinical Diagnostic Market Attractiveness Index, By Product – 2022-2032
Figure 68: MEA Clinical Diagnostic Market Share, By Country, 2022 & 2032
Figure 69: MEA Clinical Diagnostic Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 70: MEA Clinical Diagnostic Market Attractiveness Index, By Country – 2022-2032
Figure 71: Asia Pacific Clinical Diagnostic Market Value (US$ Bn) and Year-on-Year Growth, 2015-2032
Figure 72: Asia Pacific Clinical Diagnostic Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Bn
Figure 73: Asia Pacific Clinical Diagnostic Market Share, By Test, 2022 & 2032
Figure 74: Asia Pacific Clinical Diagnostic Market Y-o-Y Growth Projections, By Test – 2022-2032
Figure 75: Asia Pacific Clinical Diagnostic Market Attractiveness Index, By Test – 2022-2032
Figure 76: Asia Pacific Clinical Diagnostic Market Share, By End-user, 2022 & 2032
Figure 77: Asia Pacific Clinical Diagnostic Market Y-o-Y Growth Projections, By End-user – 2022-2032
Figure 78: Asia Pacific Clinical Diagnostic Market Attractiveness Index, By End-user – 2022-2032
Figure 79: Asia Pacific Clinical Diagnostic Market Share, By Product, 2022 & 2032
Figure 80: Asia Pacific Clinical Diagnostic Market Y-o-Y Growth Projections, By Product – 2022-2032
Figure 81: Asia Pacific Clinical Diagnostic Market Attractiveness Index, By Product – 2022-2032
Figure 82: Asia Pacific Clinical Diagnostic Market Share, By Country, 2022 & 2032
Figure 83: Asia Pacific Clinical Diagnostic Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 84: Asia Pacific Clinical Diagnostic Market Attractiveness Index, By Country – 2022-2032
Figure 85: US Clinical Diagnostic Market Value (US$ Bn) and Forecast, 2022 - 2032
Figure 86: US Clinical Diagnostic Market Share, By Test, 2021
Figure 87: US Clinical Diagnostic Market Share, By End-user, 2021
Figure 88: US Clinical Diagnostic Market Share, By Product, 2021
Figure 89: Canada Clinical Diagnostic Market Value (US$ Bn) and Forecast, 2022 - 2032
Figure 90: Canada Clinical Diagnostic Market Share, By Test, 2021
Figure 91: Canada Clinical Diagnostic Market Share, By End-user, 2021
Figure 92: Canada Clinical Diagnostic Market Share, By Product, 2021
Figure 93: Brazil Clinical Diagnostic Market Value (US$ Bn) and Forecast, 2022 - 2032
Figure 94: Brazil Clinical Diagnostic Market Share, By Test, 2021
Figure 95: Brazil Clinical Diagnostic Market Share, By End-user, 2021
Figure 96: Brazil Clinical Diagnostic Market Share, By Product, 2021
Figure 97: Mexico Clinical Diagnostic Market Value (US$ Bn) and Forecast, 2022 - 2032
Figure 98: Mexico Clinical Diagnostic Market Share, By Test, 2021
Figure 99: Mexico Clinical Diagnostic Market Share, By End-user, 2021
Figure 100: Mexico Clinical Diagnostic Market Share, By Product, 2021
Figure 101: Germany Clinical Diagnostic Market Value (US$ Bn) and Forecast, 2022 - 2032
Figure 102: Germany Clinical Diagnostic Market Share, By Test, 2021
Figure 103: Germany Clinical Diagnostic Market Share, By End-user, 2021
Figure 104: Germany Clinical Diagnostic Market Share, By Product, 2021
Figure 105: U.K. Clinical Diagnostic Market Value (US$ Bn) and Forecast, 2022 - 2032
Figure 106: U.K. Clinical Diagnostic Market Share, By Test, 2021
Figure 107: U.K. Clinical Diagnostic Market Share, By End-user, 2021
Figure 108: U.K. Clinical Diagnostic Market Share, By Product, 2021
Figure 109: France Clinical Diagnostic Market Value (US$ Bn) and Forecast, 2022 - 2032
Figure 110: France Clinical Diagnostic Market Share, By Test, 2021
Figure 111: France Clinical Diagnostic Market Share, By End-user, 2021
Figure 112: France Clinical Diagnostic Market Share, By Product, 2021
Figure 113: Italy Clinical Diagnostic Market Value (US$ Bn) and Forecast, 2022 - 2032
Figure 114: Italy Clinical Diagnostic Market Share, By Test, 2021
Figure 115: Italy Clinical Diagnostic Market Share, By End-user, 2021
Figure 116: Italy Clinical Diagnostic Market Share, By Product, 2021
Figure 117: BENELUX Clinical Diagnostic Market Value (US$ Bn) and Forecast, 2022 - 2032
Figure 118: BENELUX Clinical Diagnostic Market Share, By Test, 2021
Figure 119: BENELUX Clinical Diagnostic Market Share, By End-user, 2021
Figure 120: BENELUX Clinical Diagnostic Market Share, By Product, 2021
Figure 121: Nordic Countries Clinical Diagnostic Market Value (US$ Bn) and Forecast, 2022 - 2032
Figure 122: Nordic Countries Clinical Diagnostic Market Share, By Test, 2021
Figure 123: Nordic Countries Clinical Diagnostic Market Share, By End-user, 2021
Figure 124: Nordic Countries Clinical Diagnostic Market Share, By Product, 2021
Figure 125: China Clinical Diagnostic Market Value (US$ Bn) and Forecast, 2022 - 2032
Figure 126: China Clinical Diagnostic Market Share, By Test, 2021
Figure 127: China Clinical Diagnostic Market Share, By End-user, 2021
Figure 128: China Clinical Diagnostic Market Share, By Product, 2021
Figure 129: Japan Clinical Diagnostic Market Value (US$ Bn) and Forecast, 2022 - 2032
Figure 130: Japan Clinical Diagnostic Market Share, By Test, 2021
Figure 131: Japan Clinical Diagnostic Market Share, By End-user, 2021
Figure 132: Japan Clinical Diagnostic Market Share, By Product, 2021
Figure 133: South Korea Clinical Diagnostic Market Value (US$ Bn) and Forecast, 2022 - 2032
Figure 134: South Korea Clinical Diagnostic Market Share, By Test, 2021
Figure 135: South Korea Clinical Diagnostic Market Share, By End-user, 2021
Figure 136: South Korea Clinical Diagnostic Market Share, By Product, 2021
Figure 137: GCC Countries Clinical Diagnostic Market Value (US$ Bn) and Forecast, 2022 - 2032
Figure 138: GCC Countries Clinical Diagnostic Market Share, By Test, 2021
Figure 139: GCC Countries Clinical Diagnostic Market Share, By End-user, 2021
Figure 140: GCC Countries Clinical Diagnostic Market Share, By Product, 2021
Figure 141: South Africa Clinical Diagnostic Market Value (US$ Bn) and Forecast, 2022 - 2032
Figure 142: South Africa Clinical Diagnostic Market Share, By Test, 2021
Figure 143: South Africa Clinical Diagnostic Market Share, By End-user, 2021
Figure 144: South Africa Clinical Diagnostic Market Share, By Product, 2021
Figure 145: Turkey Clinical Diagnostic Market Value (US$ Bn) and Forecast, 2022 - 2032
Figure 146: Turkey Clinical Diagnostic Market Share, By Test, 2021
Figure 147: Turkey Clinical Diagnostic Market Share, By End-user, 2021
Figure 148: Turkey Clinical Diagnostic Market Share, By Product, 2021
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
